即将开始 NCT07873619

组织碎解术用于腹膜肿瘤及淋巴结:一项先导研究

卵巢癌前列腺癌不适用I 期II 期III 期IV 期

腹膜癌的处理相当棘手。在早期阶段,若无症状,或仅出现许多疾病共有的常见症状或不适,并不容易被发现或诊断,往往在确诊时已属晚期,治疗选择有限,寿命亦受到限制。

适应症:Lymph Nodes、Peritoneal Tumour

入组条件

纳入标准

  • Age ≥ 18 years old
  • Fit for general anaesthesia
  • Peritoneal tumour (eg. intraperitoneal tumour, retroperitoneal tumour) and/or lymph node
  • Size ≤ 10cm for each peritoneal tumour and lymph node
  • With or without distant metastasis
  • Good performance status
  • Tumour visible and targetable by ultrasound with acceptable acoustic windows
  • Adequate hematologic, hepatic, and renal function

排除标准

  • Refusal to take part in clinical trial
  • Not fit for general anaesthesia
  • Poor general condition with limited life expectancy
  • Uncontrolled coagulopathy
  • Extensive bowel interposition preventing safe targeting, per recent porcine safety data linking mis-targeting to bowel injury

入组条件维持 ClinicalTrials.gov 原始英文登记资料,实际入组资格以研究团队的正式评估与受试者知情同意书为准。资料来源:ClinicalTrials.gov,每两周自动更新,最后同步:2026年11月5日。